Secreted proteins may serve as major targets in the immune response to mycobacteria. To identify potentially secreted Mycobacterium kprae antigens, antisera specific for culture filtrate proteins of Mycobacterium tuberculosis were used to screen a panel of recombinant antigens selected previously by leprosy patient sera.
specific for MPT32, a secreted M. tuberculosis protein. The DNA coding for the M. leprae antigen, which we have designated 43L, was isolated and characterized and found to encode a 25.5-kDa protein that is preceded by a consensus signal peptide of 39 amino acids. The N-terminal amino acid sequence of 43L shows 50% homology with the 20 known N-terminal amino acids of MPT32, and 47% homology was found with the N terminus of a 45/47-kDa antigen complex identified in Mycobacterium bovis BCG. These findings indicate that 43L represents an antigen related to MPT32 and the M. bovis BCG 45/47-kDa complex and that 43L is likely to be a protein secreted by M. leprae. Purified recombinant 43L protein is recognized by antibodies and T cells from healthy contacts and leprosy patients, illustrating that secreted proteins are of importance in the immune response to M. leprae.
In recent years, recombinant DNA technology has become an important tool in the identification of Mycobacterium leprae antigens that are involved in the spectrum of immune responses that can be induced upon infection with this intracellular parasite (30) . Among these antigens are heat shock proteins (HSPs), which are predominantly localized in the cytoplasm. HSPs, a large number of which were selected by using monoclonal antibodies, are prominent antigens in both T-cell and B-cell responses to M. leprae (13, 14, 31) . In addition to HSPs, secreted antigens have been shown to constitute important target structures in the immune response towards M. leprae (8, 10, 25) .
Upon infection with M. leprae, protective immunity as well as immunopathology leading to disease may be induced, and both processes are believed to be dependent on antigenspecific T-cell recognition. It is still a controversial matter whether particular M. leprae antigens may either provide protection or induce immunopathology. A role for actively secreted antigens in protective immunity has been proposed on the basis of the observation that living attenuated mycobacteria provide a higher degree of immunity than heat-killed bacteria (27) and a limited degree of protection with secreted antigens was obtained in an animal model for tuberculosis (18) . Recently, it has been demonstrated that live Mycobacterium tuberculosis predominantly provokes T-cell responses to antigens secreted by the bacteria during growth (2) . Several 
MATERIALS AND METHODS
Bacterial strains, phages, plasmids, and cosmids. The bacterial strains, phages, plasmids, and cosmids used in this study are listed in Table 1 . Strain POP2136 was used as a host for plasmid pEX2 and derivatives, and strain X2819 was used as a host for an M. leprae genomic library cloned into the cosmid pHC79 (5). Strain JM109 was used as a host for plasmids pUC13 and derivatives. Bacterial strains were grown in LB medium and LB agar (11) supplemented with ampicillin (100 ,ug/ml) and tetracycline (10 ,ug/ml).
Antibodies. Serum samples from 21 borderline tuberculoid and tuberculoid (BT/TT) leprosy patients, 17 lepromatous and borderline lepromatous (LL/BL) leprosy patients, and 10 healthy contacts (HCs) were from endemic leprosy regions in Ethiopia. These sera were used in a 1:100 dilution. Polyclonal rabbit antibodies directed against secreted proteins of M. tuberculosis were K12 and K13 directed against MPT63, K14 and K15 directed against MPT51, K16 and K17 directed against MPT53, K23 directed against total secreted proteins of M. tuberculosis, K95 directed against MPT64, and K180 and K190 directed against MPT32 (15) . These sera were used in a 1:200 dilution. Horseradish peroxidase- Production of recombinant fusion proteins. Expression of cro-lacZ hybrid genes from pEX2 derivatives was induced as described previously (26) . For T-cell proliferation assays, lysates of Escherichia coli were centrifuged (10 min, 12 ,000 x g) and the pellets, enriched in fusion proteins, were resuspended in Iscove's modified Dulbecco's medium and stored at -20°C until used.
Expression of glutathione hybrid genes from pGEX derivatives was induced by adding 1 mM IPTG (isopropyl-,3-Dthiogalactopyranoside) to a log-phase culture with an optical density at 600 nm of 0.5. The culture was maintained for another 3 h at 37°C. Cells were pelleted by spinning the culture for 30 min at 1,000 x g. Cells were resuspended to an optical density at 600 nm of 5 in lysis buffer (30% sucrose, 50 mM Tris-HCl [pH 8], 100 mM KCl, 1 mM dithioerythritol, 5 mM EDTA). Ten percent sarcosyl solution (10% N-lauryl sarcosine in H20) was added to a final concentration of 0.2%. After mixing and sonication (six times for 30 s at 80 W in a Branson sonifier B-12 sonicator), the cell extract was frozen at -20°C until use. In order to purify the fusion protein, we performed affinity chromatography, using a glutathione-binding column according to the manufacturer's instructions (Pharmacia P-L Biochemicals, Inc., Milwaukee, Wis.). Purification of the native 43L antigen after cleavage of the glutathione fusion product with thrombin was performed as described elsewhere (23) . Proteins were >90% pure, as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and were stored at -20°C until use.
SDS-PAGE and immunoblotting. Production of recombinant (fusion) proteins in E. coli lysates was analyzed by SDS-PAGE on 7.5 or 12% acrylamide gels and by Western blotting (immunoblotting). SDS-PAGE was done according to the method of Laemmli (9) , and electrophoresis was performed at 70 mA. Either the gels were stained with Coomassie brilliant blue or the proteins were transferred to nitrocellulose membranes (type BA83; 0.2-,um-pore-size filters; Schleicher & Schuell, Dassel, Germany) in a Bio-Rad transfer apparatus according to the recommendations of the manufacturer (Bio-Rad Laboratories, Richmond, Calif.). Immunoblotting of the membranes with pooled patient sera or monospecific polyclonal rabbit antisera was done as described previously (1) . Patient sera were used in a 1:100 dilution. The monospecific polyclonal rabbit antisera were used in a 1:200 dilution.
DNA analysis and sequencing. Restriction endonucleases were used as specified by the manufacturer (Promega Corporation, Madison, Wis.) Standard procedures were used for preparation of plasmid and cosmid DNAs. Southern blotting and hybridization were performed as described previously (11) with nylon membranes (Hybond-N+; Amersham International, Amersham, Buckinghamshire, United Kingdom). Hybridization buffer and hybridization conditions used were as specified for the Hybond-N+ membranes. Washing was performed under conditions of medium stringency, one time for 10 min at room temperature with 2x SSPE (lx SSPE is 10 mM Na2HPO4, 0.18 M NaCl, and 1 mM EDTA [pH 7.7]) followed by one time for 10 min at 65°C with lx SSPE. Probe labelling with ot-32P was done as specified by the manufacturer (Promega Corporation) with the use of a random-primed labelling kit. The EcoRI DNA insert from Xgtll recombinant clone L14 was subcloned into the EcoRI site of the expression vector pEX2 by PCR as described by Thole et al. (25) .
Nucleotide sequence analysis was performed on plasmid and cosmid DNAs that had been purified by CsCl-gradient centrifugation (11) , by the dideoxy chain-termination method (21) (22) . These clones were grouped by hybridization studies and were shown to express at least 22 novel antigenic determinants. By immunoblotting, we tested whether antigens expressed by 25 representative members of this large panel of clones were recognized by antiserum K23 directed against total culture filtrate proteins of M. tuberculosis. The gene products of five Agtll clones (L2, L7, L14, L24, and L44) were recognized (Fig. 1, L7 and L14 ). This indicated that these clones produce potentially secreted M. leprae antigens. The reactivity with antigens produced by L7 and L44 was not unexpected, since these clones express parts of the M. leprae B component of the secreted antigen 85 complex (25) . To further characterize the antigens expressed by L2, L14, and L24, they were tested for recognition by monospecific polyclonal rabbit antibodies directed to individual secreted proteins of M. tuberculosis. This revealed that the antigen expressed by L2 was recognized by antibodies to MPT53, a 15-kDa protein. The antigen expressed by L14 was recognized by antibodies directed to MPT32, a 41-kDa protein, whereas the antigen expressed by L24 was not recognized by any of the tested antisera against individual secreted proteins of M. tuberculosis. In this study, we have focused on the protein expressed by L14.
Subcloning of L14 in expression systems. In order to generate large quantities and to purify the antigen expressed by L14, the 1-kb EcoRI PCR fragment of L14 was subcloned into the EcoRI sites of pEX2 and pGEX-1lT. The insert orientation was checked by comparing fusion protein sizes of the cro-3-galactosidase and the glutathione fusion products with the expected protein size from the original Xgtll clone. A characteristic doublet can be seen in both Coomassie-stained SDS-PAGE and in Western blots probed with anti-MPT32 and anti-M. tuberculosis total secreted protein (Fig. 1) . Recombinant native complete antigen shows a similar doublet band of 27/32 kDa (see the description below and Fig. 4) . Although much smaller, these bands could correspond to the observed double bands reported for the corresponding 45/47-kDa complex antigens of Mycobactenium bovis BCG (20) .
Molecular analysis of pEX2/L14 and derivatives. The complete M. leprae DNA insert of pEX2/L14 was sequenced and found to be 1,080 bp long. The analysis of this DNA fragment revealed the presence of an open reading frame (ORF) predicting a protein consisting of 230 amino acids fused to 3-galactosidase. To obtain the complete gene, the EcoRI insert of the L14 clone was used as a probe to screen a cosmid library. Two cosmid clones, designated pYA1108 and pYA1109, were isolated. A 4.3-kb PstI fragment from pYA1108 hybridized with the 1.0-kb fragment of clone L14, and a PstI fragment with a similar size was detected in genomic M. leprae DNA. The 4.3-PstI fragment from pYA1108 was subcloned into pUC13, resulting in plasmid pYA1110 (Fig. 2) . By using this plasmid, the region corresponding to the insert of pEX2/L14, as well as 245 bp at the 5'-terminal end of this region, was sequenced. This resulted in a DNA sequence of 1,325 bp, as shown in Fig. 3 . Analysis of this DNA fragment revealed an ORF corresponding with the ORF in pEX2/L14. The ORF starts at position 75 and ends at position 935. An additional start codon in the same reading frame is present at position 165. Computer analysis revealed a putative signal sequence between positions 75 and 191, encoding a 39-amino-acid signal peptide that includes a consensus Ala-Asn-Ala cleavage site at its C terminus (16) , which would correspond with its identification as a potentially secreted M. leprae protein.
The first 20 N-terminal amino acids showed extensive homology with the N terminus of MPT32 and the N terminus of a 45/47-kDa complex of M. bovis BCG (Fig. 4 [15, 20] ).
The presence of a similar gene in M. tuberculosis was confirmed by hybridization of the 1.0-kb EcoRI fragment of clone pEX2/L14 to a homologous band in genomic M. tuberculosis DNA (Fig. 5) . Given also the reactivity of the anti-MPT32 sera to the product expressed by L14, which does not contain this N-terminal region, we conclude from these data that we have identified and characterized an M. leprae antigen related to MPT32 and the M. bovis BCG 45/47-kDa complex. We have designated the M. leprae antigen 43L, corresponding to the nomenclature for MPT32 (43T) listed in a recent compilation of mycobacterial protein antigens (30) .
To purify native recombinant 43L, PCR-amplified M. leprae DNA encoding the mature protein was subcloned into the expression vector pGEX-1XT and purified from the expressed glutathione fusion protein after cleavage with thrombin as described in Materials and Methods. Native mature 43L migrates with a mobility of 27 and/or 32 in SDS-PAGE, corresponding to the calculated molecular mass of the mature protein of 25,553 Da (Fig. 4) . The molecular mass of 43L thus is considerably smaller than the estimated molecular masses of 41 kDa for MPT32 and of 45/47 kDa for the M. bovis BCG 45/47 kDa complex.
Immunological analysis of the secreted M. patient sera, immunoblotting was performed with purified native 43L and serum samples from LL/BL patients, BT/7T patients, and HCs. Of the 17 tested LL/BL patient samples, 15 were shown to strongly recognize recombinant 43L. Eleven of 21 BT/TT patient serum samples gave a moderate reaction, and a weak reactivity with 43L was found in 3 of 10 tested healthy contacts. A representative number of these reactivities are shown in Fig. 6 . The data indicate that 43L is recognized by the majority of the tested LL/BL sera but that the reactivity in TT/BT patients and HCs is generally much weaker.
In order to assess T-cell recognition of this antigen, proliferation of peripheral blood mononuclear cells derived from HCs, LL/BL patients, and BTFJ1T patients was tested in the presence of a semipurified lysate containing the fusion protein expressed by pEX2/L14. Despite the semipurified nature of the antigen preparations, significant proliferation was found in 4 of 21 HCs, in 4 of 29 BTFTT patients and in 1 of 18 LL/BL patients tested (data not shown). In concordance with these data, purified native 43L is recognized by peripheral blood lymphocytes from two of two tested HCs and two of three tested BT/TT or LL/BL patients ( Table 2 ).
The T-cell and antibody recognition indicates that antigen 43L is recognized by HCs and by patients throughout the leprosy spectrum. (20) . The N-terminal sequence of M. tuberculosis MPT32 shows a distinct difference from the N-terminal sequence of the M. bovis BCG 45/47-kDa protein at residues 1, 3, and 11 (Fig. 4) (15, 20) . This difference in molecular mass may be accounted for by differential posttranslational modification, yielding a larger product in the case of naturally expressed protein in M. leprae than for the expression in E. coli. In this regard, it should be noted that evidence for glycosylation of mycobacterial proteins has recently been presented for the M. tuberculosis antigen (7) . This issue can be further investigated after expression of 43L in a mycobacterial host (12) .
Secreted proteins are believed to be important in the immune response to M. leprae. The secreted proteins analyzed so far are shown to elicit a T-cell response and a B-cell response in leprosy patients and HCs. This is shown for the antigen 85 complex (19, 25) . Secreted proteins of M. leprae have been difficult to identify, largely due to the inability to culture M. leprae in vitro. The current study demonstrates that this problem can be circumvented by using antisera directed against secreted proteins of M. tuberculosis. This approach is limited by the use of rabbit antisera directed to M. tuberculosis. Secreted proteins of M. leprae that display less or no homology with M. tuberculosis will therefore not be detected. Furthermore, the rabbit's immune system might be unresponsive to certain antigens. Therefore, among the 25 recombinants tested, there may be additional secreted proteins to clones identified in this study.
Immune responses to secreted proteins might be particularly important in the initial phase of infection. M. leprae is capable of surviving intracellularly in resting macrophages. Secreted proteins of M. leprae may induce immune responses in an early stage because of their accessibility to the immune system. In this early stage, they can be processed and presented in combination with major histocompatibility complex molecules on the surface of macrophages, thereby stimulating T cells that can initiate activation of the resting macrophages and causing removal of intracellular bacteria. The observation that putative secreted M. leprae protein 43L indeed elicits T-cell and B-cell responses in a number of HCs, BTFIT patients, and LL/BL patients supports this hypothesis. This study confirms the assumption that secreted M. leprae proteins may induce both cellular and humoral immune responses in patients and controls, regardless of the ability of these individuals to respond to total M. leprae (17) . Several of the most prominent mycobacterial antigens identified thus far are HSPs. Such HSPs are evolutionarily conserved and share homology with eukaryotic HSPs. Consequently, the immune system recognizing mycobacterial HSPs may cross-react with human HSPs. The antigen recognized by T and B cells described in this study may be important in the light of vaccine development, since it would not provoke an autoimmune reaction, possibly as a result of its expression being restricted to mycobacteria.
